Literature DB >> 10977420

Cost of treating influenza in emergency department and hospital settings.

F M Cox1, M M Cobb, W Q Chua, T P McLaughlin, L J Okamoto.   

Abstract

OBJECTIVES: To provide an estimate of the costs of treating influenza in emergency department and hospital settings. STUDY
DESIGN: Retrospective, descriptive study using patient-level data from the Perspective Comparative Database. PATIENTS AND METHODS: We analyzed clinical and cost data obtained from 75 of the 169 hospitals in the database. These hospitals were located throughout the United States. Patients were included in the study if they visited the emergency department between January 1, 1997, and June 30, 1998, and had a primary diagnosis of influenza.
RESULTS: A total of 1362 patients with influenza visited the emergency department during the study period. Of these, 333 (24.4%) required hospitalization. The mean cost of treatment for patients discharged directly from the emergency department was $141.89; the mean cost of treatment for hospitalized patients was $3251.04. The mean length of stay for hospitalized patients was 4.3 days. Compared with younger patients, elderly patients were more likely to be hospitalized and incur higher costs. Thirty-eight percent of hospitalized patients for whom drug data were available received either amantadine or rimantadine during their stay.
CONCLUSIONS: Few data are available documenting resource utilization and associated costs for patients with influenza treated in the emergency department or hospital. Our results represent a significant addition to the identification of the costs associated with the treatment of influenza. This suggests early intervention care aimed at minimizing the impact of influenza, especially in the elderly, could result in decreased hospitalizations and substantial cost savings to managed care.

Entities:  

Mesh:

Year:  2000        PMID: 10977420

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  8 in total

1.  [Study of flu costs].

Authors:  Xavier Badia Llach; Montserrat Roset Gamisans; José M Francés Tudel; Concha Alvarez Sanz; Carlos Rubio Terrés
Journal:  Aten Primaria       Date:  2006-09-30       Impact factor: 1.137

Review 2.  Antivirals for influenza: strategies for use in pediatrics.

Authors:  Steven M Smith; John G Gums
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

3.  Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients.

Authors:  Andrea Freyer Dugas; Sara Coleman; Charlotte A Gaydos; Richard E Rothman; Kevin D Frick
Journal:  Ann Emerg Med       Date:  2013-03-20       Impact factor: 5.721

4.  Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.

Authors:  Patrick H Peters; Anne Moscona; Kathy L Schulman; Charles E Barr
Journal:  Medscape J Med       Date:  2008-06-04

5.  Management of influenza symptoms in healthy adults.

Authors:  Michael B Rothberg; Shunian He; David N Rose
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

6.  Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations.

Authors:  James C King; John H Beigel; Michael G Ison; Richard E Rothman; Timothy M Uyeki; Robert E Walker; James D Neaton; John S Tegeris; James A Zhou; Kimberly L Armstrong; Wendy Carter; Peter S Miele; Melissa S Willis; Andrea F Dugas; LaRee A Tracy; David M Vock; Rick A Bright
Journal:  Open Forum Infect Dis       Date:  2019-03-14       Impact factor: 3.835

7.  Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States.

Authors:  Charisma Y Atkins; Anita Patel; Thomas H Taylor; Matthew Biggerstaff; Toby L Merlin; Stephanie M Dulin; Benjamin A Erickson; Rebekah H Borse; Robert Hunkler; Martin I Meltzer
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

8.  Extreme precipitation and emergency room visits for influenza in Massachusetts: a case-crossover analysis.

Authors:  Genee S Smith; Kyle P Messier; James L Crooks; Timothy J Wade; Cynthia J Lin; Elizabeth D Hilborn
Journal:  Environ Health       Date:  2017-10-17       Impact factor: 5.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.